Literature DB >> 34158605

Filgotinib for ulcerative colitis.

Jordan Hindson1.   

Abstract

Entities:  

Year:  2021        PMID: 34158605     DOI: 10.1038/s41575-021-00483-9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN: 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

1.  Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.

Authors:  Brian G Feagan; Silvio Danese; Edward V Loftus; Séverine Vermeire; Stefan Schreiber; Timothy Ritter; Ronald Fogel; Rajiv Mehta; Sandeep Nijhawan; Radosław Kempiński; Rafał Filip; Ihor Hospodarskyy; Ursula Seidler; Frank Seibold; Ian L P Beales; Hyo Jong Kim; John McNally; Chohee Yun; Sally Zhao; Xiaopeng Liu; Chia-Hsiang Hsueh; Chantal Tasset; Robin Besuyen; Mamoru Watanabe; William J Sandborn; Gerhard Rogler; Toshifumi Hibi; Laurent Peyrin-Biroulet
Journal:  Lancet       Date:  2021-06-03       Impact factor: 79.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.